Therabene
American biotechnology company
From Wikipedia, the free encyclopedia
Therabene is an American biotechnology company founded in 2020 that develops PROTAC drugs targeting proteins such as CDK9 and MYC for cancer treatment.[1][2]
Company typePrivate
IndustryBiotechnology
FoundedMansfield, Massachusetts, U.S.
HeadquartersNorwood, Massachusetts, U.S.
| Company type | Private |
|---|---|
| Industry | Biotechnology |
| Founded | Mansfield, Massachusetts, U.S. |
| Headquarters | Norwood, Massachusetts, U.S. |
Key people | Mario DiPaola (CEO) Zoser Mohamed (President) Oscar Kashala (CMO) |
| Website | www |
History
Therabene was founded in 2020 by Mario DiPaola and initially operated from the Mansfield Bio-Incubator. The company later relocated its headquarters to Norwood, Massachusetts.[3][4][5]
In 2024, it reported preclinical results for two molecules showing tumor reduction in a triple-negative breast cancer model. In 2025, Oscar L. Kashala was appointed chief medical officer.[6][7][8]